BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8697090)

  • 1. [Multiple gene alterations involved in the processor of human gastric carcinogenesis].
    Lu Y; Li Z; Sun M
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):679-82, 710-1. PubMed ID: 8697090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
    Li Z; Lü Y
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
    Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
    Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
    Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
    Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions.
    Xi YG; Ding KY; Su XL; Chen DF; You WC; Shen Y; Ke Y
    Carcinogenesis; 2004 Nov; 25(11):2201-6. PubMed ID: 15240512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of multiple gene changes with malignant phenotype of human gastric carcinoma].
    Gao C; Lu Y
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):671-5. PubMed ID: 9275549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
    Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
    Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
    Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
    Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic events in gastric carcinogenesis.
    Correa P; Shiao YH
    Cancer Res; 1994 Apr; 54(7 Suppl):1941s-1943s. PubMed ID: 8137316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
    Gomyo Y; Osaki M; Kaibara N; Ito H
    Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach.
    Tan XH; Zhao M; Pan KF; Dong Y; Dong B; Feng GJ; Jia G; Lu YY
    Cancer Lett; 2005 Mar; 220(1):101-14. PubMed ID: 15737693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
    Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
    Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The alteration of MTS1 gene in precancerous lesions and squamous cell carcinoma of oral mucosa].
    Wang WX; Sun SZ; Yang PS; Ma BL; Long Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):361-3. PubMed ID: 14680586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.